Genentech Company Updates | Glassdoor

Company Updates

  • COVID-19

    Doing our part during the COVID-19 crisis means going beyond our vital day-to-day work to advance science. We’re committing $42 million to provide immediate and long-term support to our communities, including low-income households and people of color disproportionately impacted by the pandemic. This support includes emergency response grants as well as funds for longer-term recovery efforts to mitigate ongoing challenges posed by the breadth and depth of this health crisis. Learn more about the three principles that have guided our approach to giving from Kristin Campbell Reed, our Senior Director of Corporate and Employee Giving.

  • COVID-19

    We take the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. Learn more here:

  • Shout out to our employees for naming us as one of Fortune Magazine's 100 Best Places to Work for the 22nd year in a row! We're thankful for our exceptional employees who make the great work here possible. Check out the full list below!

  • Last week our African Americans in Biotechnology employee resource group kicked off Black History Month with a standing room only event featuring the family of Henrietta Lacks. Huge thanks to the Lacks family for joining us and sharing Henrietta's legacy firsthand, one that has helped to revolutionize modern medicine. Learn more about our employee resource groups below!

  • Disease targets once thought impossible to attain are coming within our grasp thanks to advanced scientific approaches. Find out how our scientists are challenging themselves to break new ground and expand the frontiers of what medicine can do.

  • Congratulations to Dr. Sandra Horning for being selected as Healthcare Businesswomen’s Association Woman of the Year! During her decade-long tenure with Roche and Genentech, she helped bring 15 new medicines to patients and worked to tackle some of the world’s toughest diseases. We're thankful for her incredible contributions to medicine & to our employees who have been inspired by her commitment to science, patients & women in leadership.

  • Why are scientists excited about biomarkers and big data? In S3E05 of our podcast, David Shames and Mark Lee explain how big data approaches could potentially aid in delivering more personalized care to patients.

  • This week marks Merone Roose-Girma’s 20th anniversary at Genentech. Learn about her journey and passion for mentoring other women of color who want to bring their authentic selves to work. #WomenOfGenentech

  • Sabbaticals have become part of our culture—where every full-time employee has the opportunity to take six weeks of paid time off every six years. It’s a perk that goes beyond just our employees because many are using their time to benefit their families, communities, co-workers and people around the world.

  • It took a village in Venezuela to make the discovery that would change the future of research in Huntington’s disease (HD), a rare, neurological disorder. Learn more about the global collaboration among scientists, HD families and industry partners that has helped advance research in HD. http://glassdoor.com/slink.htm?key=vMLnd

Work at Genentech? Share Your Experiences

Genentech
  • Star
  • Star
  • Star
  • Star
  • Star
 
Click to Rate
or